Bioatla Inc (BCAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 0 | 11,000 | 0 | 0 | 0 |
| Gross Profit | N/A | 11,000 | N/A | N/A | N/A |
| Operating Expenses | 16,244 | 22,270 | 21,972 | 24,457 | 28,536 |
| Operating Income | -16,244 | -11,270 | -21,972 | -24,457 | -28,536 |
| Other Income | 1,360 | 684 | 900 | 1,223 | 1,611 |
| Pre-tax Income | -14,884 | -10,586 | -21,072 | -23,234 | -26,925 |
| Net Income Continuous | -14,884 | -10,586 | -21,072 | -23,234 | -26,925 |
| Net Income | $-14,884 | $-10,586 | $-21,072 | $-23,234 | $-26,925 |
| EPS Basic Total Ops | -15.00 | -11.00 | -22.00 | -24.00 | -27.50 |
| EPS Basic Continuous Ops | -14.86 | -10.95 | -21.85 | -24.16 | -28.04 |
| EPS Diluted Total Ops | -15.00 | -11.00 | -22.00 | -24.00 | -27.50 |
| EPS Diluted Continuous Ops | -14.86 | -10.95 | -21.85 | -24.16 | -28.04 |
| EPS Diluted Before Non-Recurring Items | -16.00 | -11.00 | -22.00 | -24.00 | N/A |
| EBITDA(a) | $-16,016 | $-11,042 | $-21,743 | $-24,217 | $-28,168 |